Biotest AG: Biotest confirms good tolerability and efficacy of Intratect(R) in primary and secondary
Search jobs 22-Apr-2021 Biotest AG: Biotest confirms good tolerability and efficacy of Intratect(R) in primary and secondary immunodeficiencies in an observational study DGAP-News: Biotest AG / Key word(s): Study 22.04.2021 / 07:00 PRESS RELEASE (R) in primary and secondary immunodeficiencies in an observational study - Proven reduction of infections in patients with secondary antibody deficiency - Enhanced quality of life during treatment - Good tolerability allows reduction of pre-medication Dreieich, 22 April 2021. Intratect (R) is a human ...
Source: pharmiweb.com